GUGGENHEIM CAPITAL LLC - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 224 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$2,153,000
+329.7%
119,705
+70.3%
0.02%
+240.0%
Q1 2020$501,000
-75.0%
70,285
-16.4%
0.01%
-66.7%
Q4 2019$2,008,000
+13.6%
84,082
+27.6%
0.02%
+7.1%
Q3 2019$1,768,000
-8.2%
65,912
-7.1%
0.01%
-12.5%
Q2 2019$1,925,000
-22.7%
70,968
-1.1%
0.02%
-20.0%
Q1 2019$2,491,000
+37.6%
71,778
-22.6%
0.02%
+33.3%
Q4 2018$1,810,000
-27.4%
92,726
-0.9%
0.02%
-6.2%
Q3 2018$2,492,000
-12.9%
93,565
+23.6%
0.02%
-15.8%
Q2 2018$2,861,000
+10.5%
75,730
-4.6%
0.02%
+216.7%
Q1 2018$2,590,000
-21.5%
79,354
+17.0%
0.01%
-25.0%
Q4 2017$3,300,000
-49.3%
67,810
-43.7%
0.01%
-46.7%
Q3 2017$6,503,000
+34.4%
120,362
+39.7%
0.02%
+15.4%
Q2 2017$4,839,000
+61.7%
86,149
+12.9%
0.01%
+62.5%
Q1 2017$2,992,000
+35.9%
76,329
-22.2%
0.01%
+33.3%
Q4 2016$2,202,000
-6.3%
98,107
-5.2%
0.01%
-14.3%
Q3 2016$2,350,000
-2.2%
103,479
+1.6%
0.01%
-12.5%
Q2 2016$2,403,000
+21.9%
101,806
+5.3%
0.01%
+33.3%
Q1 2016$1,972,000
-65.3%
96,649
-12.5%
0.01%
-64.7%
Q4 2015$5,682,000
-11.2%
110,438
-26.4%
0.02%
-15.0%
Q3 2015$6,398,000
-15.4%
150,128
-9.6%
0.02%
+5.3%
Q2 2015$7,567,000
+32.3%
166,116
+10.2%
0.02%
+35.7%
Q1 2015$5,721,000
+47.4%
150,710
+10.0%
0.01%
+40.0%
Q4 2014$3,880,000136,9990.01%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Grace Capital 270,832$6,467,0005.27%
Fernwood Investment Management, LLC 336,111$8,026,0003.84%
Tamarack Advisers, LP 595,000$14,268,0003.26%
First Light Asset Management, LLC 1,008,957$24,094,0003.08%
NEXPOINT ASSET MANAGEMENT, L.P. 1,540,679$36,791,0002.79%
CADIAN CAPITAL MANAGEMENT, LP 2,133,343$50,944,0002.25%
SECTORAL ASSET MANAGEMENT INC 606,189$14,476,0002.16%
Asymmetry Capital Management, L.P. 49,431$1,180,0002.12%
Parkman Healthcare Partners LLC 275,505$6,579,0001.90%
HARVEY CAPITAL MANAGEMENT INC 150,751$3,599,0001.60%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders